Canada markets closed

Ultimovacs ASA (ULTI.OL)

Oslo - Oslo Delayed Price. Currency in NOK
Add to watchlist
6.98+0.02 (+0.29%)
At close: 04:26PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
123,834
123,834
95,175
96,735
64,660
Selling General and Administrative
6,476
6,476
9,246
5,061
3,978
Total Operating Expenses
215,734
215,734
183,630
163,832
124,146
Operating Income or Loss
-215,734
-215,734
-183,630
-163,832
-124,146
Interest Expense
-
-
-
333
240
Income Before Tax
-189,239
-189,239
-167,792
-164,722
-120,552
Income Tax Expense
0
0
0
0
0
Income from Continuing Operations
-189,239
-189,239
-167,792
-164,722
-120,552
Net Income
-189,239
-189,239
-167,792
-164,722
-120,552
Net Income available to common shareholders
-189,239
-189,239
-167,792
-164,722
-120,552
Basic EPS
-6.00
-
-4.90
-5.10
-4.00
Diluted EPS
-6.00
-
-4.90
-5.10
-4.00
Basic Average Shares
34,374
-
34,247
32,373
30,260
Diluted Average Shares
34,374
-
34,247
32,373
30,260